149 related articles for article (PubMed ID: 15000891)
1. Risk factors of adverse drug reaction from non-steroidal anti-inflammatory drugs in Shanghai patients with arthropathy.
Shi W; Wang YM; Li SL; Yan M; Li D; Chen BY; Cheng NN
Acta Pharmacol Sin; 2004 Mar; 25(3):357-65. PubMed ID: 15000891
[TBL] [Abstract][Full Text] [Related]
2. [Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs].
Shi W; Wang YM; Cheng NN; Chen BY; Li D
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1044-8. PubMed ID: 14687510
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
Layton D; Hughes K; Harris S; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of adverse drug reaction caused by nimesulide in Shanghai patients with osteoarthropathy.
Shi W; Wang YM; Li SL; Yan M; Chen BY; Chen NN; Li D
Drugs Exp Clin Res; 2003; 29(4):161-8. PubMed ID: 15018308
[TBL] [Abstract][Full Text] [Related]
5. Adverse effect of drug-induced emotional problems on work and daily activities. A principal component as an independent predictor of ADRs in Shanghai patients with osteo-arthropathy taking nabumetone.
Shi W; Wang YM; Li SL; Yan M
Int J Clin Pharmacol Ther; 2004 Jun; 42(6):321-7. PubMed ID: 15222724
[TBL] [Abstract][Full Text] [Related]
6. Application of a propensity score to adjust for channelling bias with NSAIDs.
Morant SV; Pettitt D; MacDonald TM; Burke TA; Goldstein JL
Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):345-53. PubMed ID: 15170763
[TBL] [Abstract][Full Text] [Related]
7. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs.
MacDonald TM; Morant SV; Goldstein JL; Burke TA; Pettitt D
Gut; 2003 Sep; 52(9):1265-70. PubMed ID: 12912856
[TBL] [Abstract][Full Text] [Related]
8. NSAIDs for the new decade--nabumetone?
Huskisson EC
Eur J Rheumatol Inflamm; 1991; 11(3):1-2. PubMed ID: 1365475
[No Abstract] [Full Text] [Related]
9. Meloxicam.
Fleischmann R; Iqbal I; Slobodin G
Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
[TBL] [Abstract][Full Text] [Related]
10. Meloxicam--a safer NSAID?
Drug Ther Bull; 1998 Aug; 36(8):62-4. PubMed ID: 9876404
[No Abstract] [Full Text] [Related]
11. Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.
Lacroix I; Lapeyre-Mestre M; Bagheri H; Pathak A; Montastruc JL; ;
Fundam Clin Pharmacol; 2004 Apr; 18(2):201-6. PubMed ID: 15066135
[TBL] [Abstract][Full Text] [Related]
12. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance.
Prieto A; De Barrio M; Martín E; Fernández-Bohórquez M; de Castro FJ; Ruiz FJ; Herrero T; Tornero P; Rubio M
J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL
Lancet; 2010 Jul; 376(9736):173-9. PubMed ID: 20638563
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice.
Lanas A; Boers M; Nuevo J
Ann Rheum Dis; 2015 Apr; 74(4):675-81. PubMed ID: 24351518
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
16. Adverse and Hypersensitivity Reactions to Prescription Nonsteroidal Anti-Inflammatory Agents in a Large Health Care System.
Blumenthal KG; Lai KH; Huang M; Wallace ZS; Wickner PG; Zhou L
J Allergy Clin Immunol Pract; 2017; 5(3):737-743.e3. PubMed ID: 28110055
[TBL] [Abstract][Full Text] [Related]
17. Channelling of patients taking NSAIDs or cyclooxygenase-2-specific inhibitors and its effect on interpretation of outcomes.
MacDonald TM; Pettitt D; Lee FH; Schwartz JS
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii3-10. PubMed ID: 14585912
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal medications and procedures in osteoarthritis patients treated with rofecoxib compared with nonselective NSAIDs.
Watson DJ; Harper SE; Zhao PL; Bolognese JA; Simon TJ
MedGenMed; 2001 Nov; 3(4):6. PubMed ID: 11965201
[TBL] [Abstract][Full Text] [Related]
19. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol.
Goldstein JL; Larson LR; Yamashita BD
Am J Manag Care; 1998 May; 4(5):687-97. PubMed ID: 10179922
[TBL] [Abstract][Full Text] [Related]
20. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
Trombetta D; Imbesi S; Vita G; Isola S; Minciullo PL; Saija A; Gangemi S
Arzneimittelforschung; 2009; 59(8):410-4. PubMed ID: 19813464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
